Midwives may independently prescribe, order and administer this drug.
Anti-fungal agent which inhibits biosynthesis. This causes damage to the fungal cell wall membrane and increases permeability.
Indications and Clinical Use:
For the treatment of vulvovaginal candidiasis and other fungal skin and mucous membrane infections.
Hypersensitivity to Miconazole or any component of the formulation.
Warnings and Precautions:
Avoid contact with eyes when using topical formulation.
Discontinue use if sensitivity or irritation occurs.
Any excess cream or ointment should be removed from the nipples before nursing.
Category L2 – No Human Data – Probably Compatible
Miconazole has poor oral bioavailability and unlikely to adversely affect the breastfed newborns, including topical application to the nipples.
Allergic dermatitis, burning, maceration, irritation and itching.
Dosage and Administration:
Topical or Intravaginal.
- Monistat® 7 cream: 15 g applicator-full intravaginally once daily at bedtime for 7 consecutive days.
- Monistat® 7 vaginal suppositories: 1 (100 mg) suppository intravaginally daily at bedtime for 7 consecutive days.
- Monistat® derm cream: Apply a thin layer of cream topically to cover the affected area twice daily. Continue treatment for 2 weeks.
- Monistat® 3 vaginal ovules: 1 (400 mg) ovule intravaginally daily at bedtime for 3 consecutive days.